The end of AIDS: HIV infection as a chronic disease, Lancet, vol.382, issue.9903, pp.1525-1558, 2013. ,
Public health considerations for the use of a first-generation HIV vaccine, AIDS, vol.17, issue.15, pp.1-10, 2002. ,
Participants of round table n°6 of Giens XXV. Vaccines: specific features, simulation of impact and medico-economic modelling, Thérapie, 2010. ,
Immune interventions in HIV infection, Immunol Rev, vol.254, issue.1, pp.355-71, 2013. ,
Therapeutic vaccination against HIV: current progress and future possibilities, Clin Sci, vol.110, issue.1, pp.59-71, 2006. ,
Therapeutic vaccines against HIV infection, Hum Vaccin Immunother, vol.8, issue.5, pp.569-81, 2012. ,
Structural insights on the role of antibodies in HIV-1 vaccine and therapy, Cell, vol.156, issue.4, pp.633-681, 2014. ,
Lessons learned from HIV Vaccine clinical efficacy trials, Curr HIV Res, vol.11, issue.6, pp.441-450, 2013. ,
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand, N Engl J Med, vol.361, issue.23, pp.2209-2229, 2009. ,
, The SAGE Vaccine Hesitancy Working Group. SAGE working group dealing with vaccine hesitancy, 2012.
Vaccine Hesitancy: Clarifying a Theoretical Framework for an Ambiguous Notion, PLOS Curr Outbreaks, vol.1, 2015. ,
Negotiating vaccine acceptance in an era of reluctance, Hum Vaccin Immunother, vol.9, issue.8, pp.1779-81, 2013. ,
Rethinking the antivaccine movement concept : a case study of public criticism pf the swine flu vaccine's safety in France, Soc Sci Med, vol.159, pp.48-57, 2016. ,
Vaccine-criticism on the internet : new insights based on French speaking websites, Vaccine, vol.33, pp.1063-70, 2015. ,
Vaccine hesitancy among general Practitionners and its determinants during controversies : a national crosssectional survey in France, Ebiomedecine, vol.2, issue.8, pp.891-898, 2015. ,
Opening the "Vaccine Hesitancy" black box : how trust in institutions affects French GP's vaccination practices, Expert Rev Vaccines, vol.15, issue.7, pp.937-985, 2016. ,
Dramatic change in public attitudes towards vaccination during the 2009 influenza a(H1N1) pandemic in France, Euro Surveill, vol.18, issue.44, 2013. ,
Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines, Lancet Infect Dis, vol.13, pp.606-619, 2013. ,
The state of Vaccine confidence 2016: global insights through a 67-country survey, EBioMedicine, vol.12, pp.295-301, 2016. ,
Positive attitudes of French general practitioners towards a/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public?, Vaccine, vol.28, issue.15, pp.2743-2751 ,
URL : https://hal.archives-ouvertes.fr/inserm-00636175
Correlates of general practitioner recommendations to patients regarding vaccination for the 2009-2010 pandemic influenza (a/H1N1) in France: implications for future vaccination campaigns, Vaccine, vol.32, pp.2281-2288, 2014. ,
Social representations of vaccination among patients and general practitioners: a study based on hierarchized evocation, Sante Publique, vol.24, issue.6, pp.547-60, 2012. ,
Understanding Vaccine Hesitancy in Canada: results of a consultation study by the Canadian immunization research network, PLoS One, vol.11, issue.6, p.156118, 2016. ,
Vaccine Hesitancy among general practitioners and its determinants during controversies: a National Cross-sectional Survey in France, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01816807
HIV vaccine acceptability: a systematic review and meta-analysis, AIDS, vol.24, issue.11, pp.1749-56, 2010. ,
Social and behavioral science in HIV vaccine trials: a gap assessment of the literature, Expert Rev Vaccines, vol.8, issue.2, pp.179-90, 2009. ,
Willingness to participate in HIV therapeutic vaccine trials among HIV-infected patients on ART in China, PLoS One, vol.9, issue.11, p.111321, 2014. ,
The brief illness perception questionnaire, J Psychosom Res, vol.60, pp.631-638, 2006. ,
Psychometric validation of the PROQOL-HIV questionnaire, a new health-related quality of life instrument-specific to HIV disease, J Acquir Immune Defic Syndr, vol.59, issue.5, pp.506-521, 2012. ,
Self-regulatory interventions for improving the management of chronic illness, pp.257-77, 2003. ,
The development of PROQOL-HIV: an international instrument to assess the health-related quality of life of persons living with HIV/AIDS, J Acquir Immune Defic Syndr, vol.59, issue.5, pp.498-505, 2012. ,
A reduced factor structure for the PROQOL-HIV questionnaire provided reliable indicators of health-related quality of life, J Clin Epidemiol, vol.72, pp.116-141, 2016. ,
Methologies for assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Athens: ISPOR 11th annual European congress, 2008. ,
Therapeutic vaccination for chronic hepatitis B, Curr Opin Virol, vol.23, pp.75-81, 2017. ,
Current state in the development of candidate therapeutic HPV vaccines, Expert Rev Vaccines, vol.15, issue.8, pp.989-1007, 2016. ,
In vitro stimulation with HBV therapeutic vaccine candidate Nasvac activates B and T cells from chronic hepatitis B patients and healthy donors, Mol Immunol, vol.63, issue.2, pp.320-327, 2015. ,
The diagnosis and treatment of prostate Cancer: a review, JAMA, vol.317, issue.24, pp.2532-2574, 2017. ,
Inadequate vaccination coverage in a French cohort of HIV positive patients, Med Mal Infect, vol.40, issue.12, pp.683-90, 2010. ,
ANRS-VESPA2 study group -health-related quality of life of people living with HIV followed up in hospitals in France: comparing trends and correlates between 2003 and 2011 (ANRS-VESPA and VESPA2 national surveys), AIDS Care, vol.26, issue.1, pp.29-40, 2014. ,